Ribosomes: the future of targeted therapies?
نویسندگان
چکیده
منابع مشابه
Ribosomes: the future of targeted therapies?
Ribosomes are ribo-nucleoprotein complexes that read mRNA to synthesize protein during translation. It is firmly established that the amount of ribosomes strongly correlates with the rate of protein synthesis and with cell growth and proliferation. Because production of ribosomes is a high energy-consuming task, ribosome biogenesis must be finely tuned to adapt the pool of functional ribosomes ...
متن کاملThe future of EPAC-targeted therapies: agonism versus antagonism
Pharmaceutical manipulation of cAMP levels exerts beneficial effects through the regulation of the exchange protein activated by cAMP (EPAC) and protein kinase A (PKA) signalling routes. Recent attention has turned to the specific regulation of EPAC isoforms (EPAC1 and EPAC2) as a more targeted approach to cAMP-based therapies. For example, EPAC2-selective agonists could promote insulin secreti...
متن کاملMolecularly targeted therapies for recurrent glioblastoma: current and future targets.
OBJECT Glioblastoma is the most aggressive and diffusely infiltrative primary brain tumor. Recurrence is expected and is extremely difficult to treat. Over the past decade, the accumulation of knowledge regarding the molecular and genetic profile of glioblastoma has led to numerous molecularly targeted therapies. This article aims to review the literature and highlight the mechanisms and effica...
متن کاملTargeted alpha anticancer therapies: update and future prospects
Targeted alpha therapy (TAT) is an emerging option for local and systemic cancer treatment. Preclinical research and clinical trials show that alpha-emitting radionuclides can kill targeted cancer cells while sparing normal cells, thus reducing toxicity. (223)RaCl2 (Xofigo(®)) is the first alpha emitting radioisotope to gain registration in the US for palliative therapy of prostate cancer bone ...
متن کاملMedullary Thyroid Carcinoma: Targeted Therapies and Future Directions
Medullary thyroid cancer (MTC) is a rare neuroendocrine neoplasm that accounts for approximately 5% of all thyroid malignancies. The natural history of MTC is characterized by early lymph node and distant metastases, making complete surgical cure often impossible. Conventional chemotherapy and external beam radiation have been largely ineffective in altering the natural history of MTC. Therefor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2013
ISSN: 1949-2553
DOI: 10.18632/oncotarget.1511